Cargando…
Pan-cancer noncoding genomic analysis identifies functional CDC20 promoter mutation hotspots
Noncoding DNA sequences occupy more than 98% of the human genome; however, few cancer noncoding drivers have been identified compared with cancer coding drivers, probably because cancer noncoding drivers have a distinct mutation pattern due to the distinct function of noncoding DNA. Here we performe...
Autores principales: | He, Zaoke, Wu, Tao, Wang, Shixiang, Zhang, Jing, Sun, Xiaoqin, Tao, Ziyu, Zhao, Xiangyu, Li, Huimin, Wu, Kai, Liu, Xue-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024666/ https://www.ncbi.nlm.nih.gov/pubmed/33851100 http://dx.doi.org/10.1016/j.isci.2021.102285 |
Ejemplares similares
-
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes
por: Wang, Shixiang, et al.
Publicado: (2021) -
Can tumor mutational burden determine the most effective treatment for lung cancer patients?
por: Wang, Shixiang, et al.
Publicado: (2020) -
Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology
por: Yao, Huizi, et al.
Publicado: (2023) -
Accurate prediction of pan-cancer types using machine learning with minimal number of DNA methylation sites
por: Ning, Wei, et al.
Publicado: (2023) -
APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
por: Wang, Shixiang, et al.
Publicado: (2018)